Constipation is a common medical condition common among elderly and women, and is interpreted differently by patients and physicians. Constipation can be chronic, sometimes severe, and has a significant, even deliberating effect on the quality of life of a patient. Various treatment options are available for the treatment of constipation and patients often adopt different over-the-counter remedies for the same. There exist three main types of constipation including:
- Chronic Idiopathic Constipation (CIC)
- Irritable Bowel Syndrome (IBS-C)
Opioid Induced Constipation (OIC).
There exist vast opportunities for prescription drugs in the constipation market. However, OTC drugs and laxatives are generally used for treating constipation, patients and physicians have started recognizing the importance of branded drugs. Future growth of the constipation market is based on continued growth of prescription therapies to treat constipation, increased research and development of novel drugs by biopharmaceutical companies, increasing patient and physician awareness of effective prescription alternatives to Over-the-Counter medications.
Growth of the constipation market is driven by several factors including rising prescription opioid consumption, growing ageing population, vast opportunity for drugs with significant potential in the U.S., rising spending on medicines, growing female population and rising healthcare expenditure. However, the growth of the market can be hindered by certain challenges including rising tide of OTC drugs for constipation and lower awareness of prescription medication for OIC.
Key Topics Covered:
1. Market Overview
2. Constipation Market Analysis
3. Chronic Constipation Market Analysis
4. Irritable Bowel Syndrome Market Analysis
5. Opioid Induced Constipation Market Analysis
6. Market Dynamics
7. Competitive Landscape
8. Company Profiles
- Ironwood Pharmaceuticals
- Sucampo Pharmaceuticals, Inc.
Synergy Pharmaceuticals, Inc.
For more information visit http://www.researchandmarkets.com/research/gpkp6s/global